Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin) : effective prophylaxis for graft-versus-host disease
Antin, J.H.; Bierer, B.E.; Smith, B.R.; Guinan, E.C.; Provost, M.M.; Ferrara, J.; Macklis, R.M.; Tarbell, N.J.; Blythman, H.; Bouloux, C.
Progress in Clinical and Biological Research 333: 207-215
1990
ISSN/ISBN: 0361-7742 PMID: 1689852 Document Number: 367175
Document emailed within 1 workday
Related Documents
Laurent, G.; Maraninchi, D.; Gluckman, E.; Vernant, J.P.; Derocq, J.M.; Gaspard, M.H.; Rio, B.; Michalet, M.; Reiffers, J.; Dreyfus, F. 1989: Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host disease Bone Marrow Transplantation 4(4): 367-371Champlin, R.; Jansen, J.; Ho, W.; Gajewski, J.; Nimer, S.; Lee, K.; Territo, M.; Winston, D.; Tricot, G.; Reichert, T. 1991: Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia Transplantation Proceedings 23(1 Pt 2): 1695-1696
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Sakamoto, K.; Sachs, D.H.; Shimada, S.; Popitz-Bergez, F.A.; Pennington, L.R.; Pescovitz, M.D.; McDonough, M.A.; MacVittie, T.J.; Katz, S.I.; Gress, R.E. 1988: Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow Transplantation 45(5): 869-875
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Liem, L.M.; van Noort, J.T.; Goulmy, E. 1996: Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin a Bone Marrow Transplantation 18(1): 73-78
Fauser, A.A.; Shustik, C.; Langleben, A.; Laurent, G.; Kanz, L.; Spurll, G.M.; Price, G.; Ahlgren, P.D.; Cooper, B.A. 1988: T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease Clinical and Investigative Medicine. Medecine Clinique et Experimentale 11(1): 40-46
Phillips, G.L.; Nevill, T.J.; Spinelli, J.J.; Nantel, S.H.; Klingemann, H.G.; Barnett, M.J.; Shepherd, J.D.; Chan, K.W.; Meharchand, J.M.; Sutherland, H.J. 1995: Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation Bone Marrow Transplantation 15(2): 213-219
Mrsić, M.; Labar, B.; Bogdanić, V.; Nemet, D.; Pavletić, Z.; Plavsić, F.; Dobrić, I.; Kastelan, A.; Marusić, M.; Zupancić-Salek, S. 1989: Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias Bone Marrow Transplantation 4(Suppl): 95-96
Martin-Algarra, S.; Bishop, M.R.; Tarantolo, S.; Cowles, M.K.; Reed, E.; Anderson, J.R.; Vose, J.M.; Bierman, P.; Armitage, J.O.; Kessinger, A. 1995: Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis Experimental Hematology 23(14): 1503-1508
Apperley, J.F.; Jones, L.; Hale, G.; Waldmann, H.; Hows, J.; Rombos, Y.; Tsatalas, C.; Marcus, R.E.; Goolden, A.W.; Gordon-Smith, E.C. 1986: Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse Bone Marrow Transplantation 1(1): 53-66
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Oluwole, S.F.; Engelstad, K.; Hardy, M.A. 1992: Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum Transplantation Proceedings 24(6): 2858-2859
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476
Jansen, J.; Goselink, H.M.; Veenhof, W.F.; Zwaan, F.E.; Blotkamp, C. 1983: The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease Experimental Hematology 11(10): 967-973
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Shaffer, D.; Simpson, M.A.; Milford, E.L.; Gottschalk, R.; Kut, J.P.; Maki, T.; Monaco, A.P. 1991: Donor pretreatment with monoclonal antibody for prevention of graft-versus-host disease following small bowel transplantation: effect of depletion of T-cell subsets Transplantation Proceedings 23(1 Pt 1): 679-681
Zenner, H.P. 1990: A monoclonal immunotoxin against laryngeal carcinoma cells Otolaryngologia Polska 44(3): 214-215
Kawata, A.; Yoshida, M.; Okazaki, M.; Yokota, S.; Barcos, M.; Seon, B.K. 1994: Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody Cancer Research 54(10): 2688-2694
Izzi, T.; Lucarelli, G. 1983: Bone marrow transplantation in humans. IV. the graft versus host disease Recenti Progressi in Medicina 74(6): 720-732